Leishmania species: models of intracellular parasitism

QUICK SEARCH:

[advanced]

	Author:		Keyword(s):

Home Help Feedback Subscriptions Archive Search Table of Contents

This Article

	Summary
	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager


Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Alexander, J.
	Articles by Russell, D. G.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Alexander, J.
	Articles by Russell, D. G.

Afonso, L. C. C., Scharton, T. M., Vieira, L. Q., Wysocka, M., Trinchieri, G. and Scott, P (1994). The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263, 235-237.[Abstract/Free Full Text]

Alexander, J. and Vickerman, K (1975). Fusion of host cell secondary lysosomes with the parasitophorous vacuoles of Leishmania mexicana infected macrophages. J.Protozool 22, 502-508.[Medline]

Alexander, J. and Russell, D. G (1992). The interaction of Leishmania species with macrophages. Advan. Parasitol 31, 175-254.[Medline]

Alexander, J., Coombs, G. and Mottram, J (1998). Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response. J. Immunol 161, 6794-6801.[Abstract/Free Full Text]

Antoine, J. C., Prina, E., Jouanne, C. and Bongrand, P (1990). Parasitophorous vacuoles of Leishmania amazonensis -infected macrophages maintain an acidic pH. Infect. Immun 58, 779-787.[Abstract/Free Full Text]

Barral, A., Teixeira, M., Reis, P., Vinhas,V., Costa, J., Lessa, H., Bittencourt, A. L., Reed, S. and Carvalho, E. M (1995). Transforming growth factor-in human cutaneous leishmaniasis. Am. J. Pathol 147, 947-954.[Abstract]

Belkaird, Y., Butcher, B. and Sacks, D. L (1998). Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: selective impairment of IL-12 induction in Leishmania infected cells. Eur. J. Immunol 28, 1369-1400.

Blackwell, J. M., Ezekowitz, R. A. B., Roberts, M. B., Channon, J. Y., Sim, R. B. and Gordon, S (1985). Macrophage complement and lectin-like receptors bind Leishmania in the absence of serum. J. Exp. Med 162, 324-329.[Abstract/Free Full Text]

Blackwell, J. M (1996). Genetic susceptibility to leishmanial infections: studies in mice and man. Parasitology 112, 67-.

Blackwell, J. M (1998). Genetics of host resistance and susceptibility to intra-macrophage pathogens: a study of multicase families of tuberculosis, leprosy and leishmaniasis in north-eastern Brazil. Int. J. Parasitol 28, 21-28.[Medline]

Bogdan, C., Gessner, A., Solbach, W. and Rollinghoff, M (1996). Invasion, control and persistence of Leishmania parasites. Curr. Opin. Immunol 8, 517-525.[Medline]

Bogdan, C. and Rollinghoff, M (1998). The immune response to Leishmania : mechanisms of parasite control and evasion. Int. J. Parasitol 28, 121-134.[Medline]

Bozza, M., Soares, M. B. P., Bozza, P. T., Satoskar, A. R., Diacovo, T. G., Brombacher, F., Titus, R. G., Shoemaker, C. B. and David, J. R (1998). The PACAP-type I receptor agonist maxadilan from sand fly saliva protects mice against lethal endotoxemia by a mechanism partially dependent of IL-10. Eur. J. Immunol 28, 1811-1816.

Brittingham, A., Morrison, C. J., McMaster, W. R., McGwire, B. S., Chang, K. P. and Mosser, D. M (1995). Role of the Leishmania surface protease gp63 in complement fixation, cell adhesion and resistance to complement-mediated lysis. J. Immunol 155, 3102-3111.[Abstract]

Carrera, L., Gazzinelli, R. T., Badolato, R., Hieny, S., Muller, W., Kuhn, R. and Sacks, D. L (1996). Leishmania promastigotes selectively inhibit interleukin-12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J. Exp. Med 183, 515-526.[Abstract/Free Full Text]

Chan, J., Fujiwara, T., Brennan, P., McNeil, M., Turco, S. J., Sibille, J., Snapper, M., Aisen, P. and Bloom, B. R (1989). Microbial glycolipids: possible virulence factors that scavange oxygen radicals. Proc. Nat. Acad. Sci. USA 82, 5910-5914.

Chang, K. P. and Dwyer, D. M (1976). Multiplication of a human parasite ( Leishmania donovani ) in the phagolysosomes of hamster macrophages in vitro. Science 193, 678-682.[Abstract/Free Full Text]

Chang, K. P (1981). Leishmania donovani macrophage binding mediated by surface glycoproteins/antigens. Mol. Biochem. Parasitol 4, 67-71.[Medline]

Channon, J. Y., Roberts, M. B. and Blackwell, J. M (1984). A study of the differential respiratory burst activity elicited by promastigotes and amastigotes of Leishmania donovani in murine resident peritoneal macrophages. Immunology 53, 345-355.[Medline]

Chatelain, R., Varkila, K. and Coffman, R. L (1992). IL-4 induces a Th2 response in Leishmania major -infected mice. J. Immunol 148, 1182-1187.[Abstract]

Collins, H. L., Schaible, U. E., Ernst, J. D. and Russell, D. J (1997). Transfer of phagocytosed particles to the parasitophorous vacuole of Leishmania mexicanas is a transient phenomenon preceding the acquisition of annexin 1 by the phagosome. J. CellSci 110, 191-200.[Abstract]

Culley, F. J., Harris, R. A., Kaye, P. M., McAdam, K. P. W. J. and Raynes, J. G (1996). C-reactive protein binds to a novel ligand on Leishmania donovani and increases uptake into human macrophages. J. Immunol 156, 4691-4696.[Abstract]

De Souza, L., Lang, T., Prina, E., Hellio, R. and Antoine, J.-C (1995). Intracellular Leishmania amazonensis amastigotes internalize and degrade MHC class II molecules of their host cells. J. Cell Sci 108, 3219-3231.[Abstract]

Descoteaux, A. and Matlashewski, G (1989). c- fos and tumor necrosis factor gene expression in Leishmania donovani- infected macrophages. Mol. Cell. Biol 9, 5223-5227.[Abstract/Free Full Text]

Desjardins, M. and Descoteaux, A (1997). Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan. J. Exp. Med 185, 2061-2068.[Abstract/Free Full Text]

Diefenbach, A., Schindler, H., Donhauser, N., Lorenz, E., Laskay, T., MacMicking, J., Rollinghoff, M., Gesser, I. and Bogdan, C (1998). Type 1 interferon (IFN/ ) and Type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 8, 77-87.[Medline]

Engwerde, C. R., Murphy, M. L., Cotterell, S. E. J., Smelt, S. C. and Kaye,P. M (1998). Neutralisation of IL-12 demonstrates the existence of discrete organ specific phases in the control of Leishmania donovani. Eur. J. Immunol 28, 669-680.[Medline]

Ferguson, M. A. J (1997). The surface glycoconjugates of trypanosomatid parasites. Philos. Trans. R. Soc. London Ser. B 352, 1295-1302.[Medline]

Frankenburg, S., Leibovici, V., Mansbach, N. and Turco, S. J (1990). Effect of glycolipids of Leishmania parasites on human monocyte activity. J. Immunol 145, 4284-4289.[Abstract]

Fruth, U., Solioz, N. M. and Louis, J. A (1993). Leishmania major interferes with antigen presentation by infected macrophages. J. Immunol 150, 1857-1863.[Abstract]

Futter, C. E., Felder, S., Schlessinger, J., Ullrich, A. and Hopkins, C. R (1993). Annexin I is phosphorylated in the multivesicular body during the processing of the epidermal growth factor receptor. J. Cell Biol 120, 77-83.[Abstract/Free Full Text]

Giorgione, J. R., Turco, S. J. and Epand, R. M (1996). Transbilayer inhibition of protein kinase. Proc. Nat. Acad. Sci. USA 93, 11634-11639.[Abstract/Free Full Text]

Gorak, P. M., Engwerda, C. R. and Kaye, P. M (1998). Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection. Eur. J. Immunol 28, 687-695.[Medline]

Green, P. J., Feizi, T., Stoll, M. S., Theil, S., Prescott, A. and McConville, M. J (1994). Recognition of the major cell surface glycoconjugates of Leishmania parasites by the human serum mannan-binding protein. Mol. Biochem. Parasitol 66, 319-328.[Medline]

Gruenheid, S., Pinner, E., Desjardins, M. and Gros, P (1997). Natural resistance to infection with intracellular pathogens: the Nramp1 protein is recruited to the membrane of the phagosome. J. Exp. Med 185, 717-730.[Abstract/Free Full Text]

Guler, M. L., Gorham, J. D., Hsieh, C. S., Mackay, A. J., Steen, R. G., Dietrich, W. F. and Murphy, K. M (1996). Genetic susceptibility to Leishmania : IL-12 responsiveness in Th1 cell development. Science 271, 984-987.[Abstract]

Guranatha, S., Sacks, D. L., Brown, D. R., Reiner, S. L., Charest, H., Glaichenhaus, N. and Seder, R. A (1997). Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmaniamajor. J. Exp. Med 186, 1137-1147.[Abstract/Free Full Text]

Guy, R. A. and Belosevic, M (1993). Comparison of receptors required for entry of Leishmaniamajor amastigotes into macrophages. Infect. Immun 61, 1553-1558.[Abstract/Free Full Text]

Hall, L. R. and Titus, R. G (1995). Sand fly saliva selectively modulates macrophage functions that inhibit killing of Leishmania major and nitric oxide production. J. Immunol 155, 3501-3506.

Hansen, B. D., Webster, H. K., Hendricks, L. D. and Pappas, M. G (1984). Leishmania mexicana : purine metabolism in promastigotes, axenic amastigotes and amastigotes derived from Vero cells. Exp. Parasitol 58, 101-109.[Medline]

Hatzigeorgiou, D. E., He, S., Sobel, J., Grabstein, K. H., Hafner, A. and Ho, J. L (1993). IL-6 down-modulates the cytokine-enhanced antileishmanial activity in human macrophages. J. Immunol 151, 3682-3691.[Abstract]

Heinzel, F. P., Sadick, M. D., Holaday, B. J., Coffman, R. L. and Locksley, R. M (1989). Reciprocal expression of interferon-or interleukin-4 during the resolution or progression of murine leishmaniasis: evidence for expansion of distinct helper T-cell subsets. J. Exp. Med 169, 59-72.[Abstract/Free Full Text]

Heinzel, F. P., Schoenhaut, D. S., Rerko, R. M., Rosser, L. E. and Gately, M. K (1993). Recombinant interleukin-12 cures mice infected with Leishmania major. J.Exp. Med 177, 1505-1509.[Abstract/Free Full Text]

Heinzel, F. P., Rerko, R. M., Ahmed, F. and Pearlman, E (1995). Endogenous IL-12 is required for control of TH2 cytokine responses capable of exacerbating leishmanaisis in normally resistant mice. J. Immunol 155, 730-739.[Abstract]

Heinzel, F. P., Rerko, R. M. and Hujer, A. M (1998). Underproduction of interleukin-12 in susceptible mice during progressive leishmanisis is due to decreased CD40 activity. Cell. Immunol 184, 129-142.[Medline]

Huber, M., Timms, E., Mak, T. W., Rollinghoff, M. and Lohoff, M (1998). Effective and long-lasting immunity against the parasite Leishmania major in CD8-deficient mice. Infect. Immun 66, 3968-3970.[Abstract/Free Full Text]

Jones, D., Elloso, M. M., Showe, L., Williams, D., Trinchieri, G. and Scott, P (1998). Differential regulation of the interleukin-12 receptor during the innate immune response to Leishmania major. Infect. Immun 66, 3818-1824.[Abstract/Free Full Text]

Julia, V., Rassoulzadegan, M. and Glaichenhaus, N (1996). Resistance to Leishmania major induced by tolerance to a single antigen. Science 274, 421-423.[Abstract/Free Full Text]

Juttner, S., Bernhagen, J., Metz, C. N., Rollinghoff, M., Bucala, R. andGessner, A (1998). Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha. J. Immunol 161, 2383-2390.[Abstract/Free Full Text]

Kamanaka, M., Yu, P., Yasui, T., Yoshida, K., Kawabe, T., Morii, T., Kishimoto, T. and Kikutani, H (1996). Protective role of CD40 in Leishmani major infection at two distinct phases of cell-mediated immunity. Immunity 4, 275-281.[Medline]

Karp, C. L., El-Safi, S. H., Wynn, T. A., Satti, M. M. H., Kordofani, A. M., Hashim, F. A., Hag-Ali, M., Neva, F. A., Nutman, T. B. and Sacks, D. L (1993). Invivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma. J. Clin. Invest 91, 1644-1648.

Kaye, P. M., Curry, A. J. and Blackwell, J. M (1991). Differential production of Th1 and Th2-derived cytokines does not determine the genetically controlled vaccine induced rate of cure in murine visceral leishmaniasis. J. Immunol 146, 2763-2770.[Abstract]

Kaye, P. M., Rogers, N. J., Curry, A. J. and Scott, J. C (1994). Deficient expression of co-stimulatory molecules on Leishmania- infected macrophages. Eur. J. Immunol 24, 2850-2854.[Medline]

Kelleher, M., Moody, S. F., Mirabile, P., Osborn, A. H., Bacic, A. and Handman, E (1995). Lipophosphoglycan blocks attachment of Leishmania major amastigotes to macrophages. Infect. Immun 62, 43-50.

Kemp, M., Kurtzhals, J. A. L., Bendtzen, K., Poulsen, L. K., Hansen, M. B., Koech, D. K., Kharazmi, A. and Theander, T. G (1993). Leishmania donovani- reactive Th1-and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis. Infect. Immun 61, 1069-1073.[Abstract/Free Full Text]

Kima, P. E., Soon, L., Chicharro, C., Ruddle, N. H. and McMahon-Pratt, D (1996). Leishmania -infected macrophages sequester endogenously synthesized parasite antigens from presentation to CD4+ T cells. Eur J. Immunol 26, 3163-3169.[Medline]

Kropf, P., Etges, R., Schopf, L., Chung, C., Sypek, J. and Muller, I (1997). Characterization of T cell-mediated responses in nonhealing and healing Leishmaniamajor infections in the absence of endogenous IL-4. J. Immunol 159, 3434-3443.[Abstract]

Kweider, M., Lesmesre, J., Darcy, F., Kusnierz, J., Capron, A. and Santoro, F (1987). Infectivity of Leishmania braziliensis promastigotes is dependent on the increasing expression of a 65,000 dalton surface antigen. J. Immunol 138, 299-305.[Abstract]

Launois, P., Maillard, I., Pingel, S., Swihart, K. G., Xenarios, I., Acha-Orbea, H., Diggelmann, H., Locksley, R. M., MacDonald, H. R. and Louis, J. A (1997). IL-4 rapidly produced Vb4Va8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity 6, 541-549.[Medline]

Leal, L. M., Moss, D. M., Kuhn, R., Muller, W. and Liew, F. Y (1993). Interleukin-4 transgenic mice of resistant background are susceptible to Leishmania major. Eur. J.Immunol 23, 566-569.[Medline]

Liew, F. Y., Li, Y. and Millott, S (1990). Tumour necrosis factor-synergises with IFN- in mediating killing of Leishmania major through the induction of nitric oxide. J.Immunol 145, 4306-4310.[Abstract]

Liew, F. Y. and O'Donnell, C. A (1993). Immunology of leishmaniasis. Adv. Parasitol 32, 161-259.

Lima, H. C. and Titus, R. G (1996). Effects of sand fly vector saliva on development of cutaneous lesions and the immune response to Leishmania braziliensis in BALB/c mice. Infect. Immun 64, 5442-5445.[Abstract]

Lo, S. K., Bovis, L., Matura, R., Zhu, B., He, S., Lum, H., Turco, S. J. and Ho, J. L (1998). Leishmania lipophosphoglycan reduces monocyte transendothelial migration: modulation of cell adhesion molecules, intercellular junctional proteins, and chemo-attractants. J. Immunol 160, 1857-1865.[Abstract/Free Full Text]

Locksley, R. M., Reiner, S. L., Hatam, F., Littman, D. R. and Killeen, N (1993). Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice. Science 261, 1448-1451.[Abstract/Free Full Text]

Love, D. C., Esko, J. D. and Mosser, D. M (1993). A heparin-binding activity on Leishmania amastigotes which mediates adhesion to cellular proteoglycans. J. CellBiol 123, 759-766.[Abstract/Free Full Text]

Macatonia, S. E., Hsieh, C. S., Murphy, K. M. and O'Garra, A (1993). Dendritic cells and macrophages are required for Th1 development of CD4+ T cells from alpha beta TCR transgenic mice: IL-12 substitution from macrophages to stimulate IFN-gamma production is IFN-gamma-dependent. Int. Immunol 5, 1119-1128.[Abstract/Free Full Text]

Mannheimer, S. B., Hariprashad, J., Stoeckle, M. Y. and Murray, H. W (1996). Induction of macrophage antiprotozoal activity by monocyte chemotactic and activating factor. FEMS Immunol 14, 59-61.

McConville, M. J. and Blackwell, J. M (1991). Developmental changes in the glycosylated phosphatidylinositols of Leishmania donovani . Characterization of the promastigote and amastigote glycolipids. J. Biol. Chem 266, 15170-15179.[Abstract/Free Full Text]

McConville, M. J., Collidge, T. A. C., Ferguson, M. A. J. and Schneider, P (1993). The glycoinositolphospholipids of Leishmania mexicana promastigotes: evidence for the presence of three distinct pathways of biosynthesis. J. Biol. Chem 268, 15595-15604.[Abstract/Free Full Text]

Medina-Acosta, E., Karess, R. E., Schwartz, R. and Russell, D. G (1989). The promastigote surface protease (gp63) of Leishmania is expressed but differentially processed and localized in the amastigote stage. Mol. Biochem. Parasitol 37, 263-274.[Medline]

Miralles, G. D., Stoeckle, M. Y., McDermott, D. F., Finkelman, F. D. and Murray, H. W (1994). Th1 and Th2 cell associated cytokines in experimental visceral leishmaniasis. Infect. Immun 62, 1058-1063.[Abstract/Free Full Text]

Moll, H., Fuchs, H., Blank, C. and Rollinghoff, M (1993). Langerhans cells transport Leishmania major from infected skin to the draining lymph node for presentation to antigen-specifc T cells. Eur. J. Immunol 23, 1595-1601.[Medline]

Moll, H., Ritter, U., Flohe, S., Erb, K., Bauer, C. and Blank, C (1996). Cutaneous leishmaniasis: a model for analysis of the immuno-regulation by accessory cells. Med. Microbiol. Immunol 184, 163-168.

Moody, S. F., Handman, E., McConville, M. J. and Bacie, A (1993). The structure of Leishmania major amastigote lipophosphoglycan. J. Biol. Chem 268, 18457-18466.[Abstract/Free Full Text]

Moore, K. J. and Matlashewski, G (1994). Intracellular infection by Leishmania donovani inhibits macrophage apoptosis. J. Immunol 152, 2930-2937.[Abstract]

Mosser, D. M., Vlassara, H., Edelson, P. J. and Cerami, A (1989). Leishmania promastigotes are recognized by the macrophage receptor for advanced glycosylation endproducts. J. Exp. Med 165, 140-145.[Abstract/Free Full Text]

Mosser, D. M. and Rosenthal, L. A (1993). Leishmania -macrophage interaction: multiple receptors, multiple ligands, and diverse cellular responses. Semin. Cell Biol 40, 63-76.

Mottram, J. C., Brooks, D. R. and Coombs, G. H (1998). Roles of cysteine proteinases of trypanosomes and Leishmania in host-parasite interactions. Curr. Opin. Microbiol 1, 455-460.

Murphy, M. L., Engwerda, C. R., Gorak, P. M. A. and Kaye, P. M (1997). B7-2 blockade enhances T cell responses to Leishmania donovani. J. Immunol 159, 4460-4466.[Abstract]

Murphy, M., Cotterell, S. E. J., Gorak, P. M., Engwerde, C. R. and Kaye, P. M (1998). Blockade of CTLA-4 enhances host resistance to the intracellular pathogen, Leishmania donovani. J. Immunol 161, 4153-4160.[Abstract/Free Full Text]

Nabors, G. S., Alfonso, L. C. C., Farrell, J. P. and Scott, P (1995). Switch from a type-2 to a type-1 T-helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy withinterleukin-12 and pentostam. Proc. Nat. Acad. Sci. USA 92, 3142-3146.[Abstract/Free Full Text]

Noben-Trauth, N., Kopf, P. and Muller, I (1996). Susceptibility to Leishmaniamajor in interleukin-4 deficient mice. Science 271, 987-990.[Abstract]

Peidrafita, D., Proudfoot, L., Nikolaev, A. V., Xu, D., Sands, W., Feng, G.-J., Thomas, E., Brewer, J., Ferguson, M. A. J., Alexander, J. and Liew, F. Y (1999). Regulation of interleukin 12 synthesis in macrophages by Leishmania phosphoglycans. Eur. J. Immunol 29, 235-244.[Medline]

Peters, C., Aebischer, T., Stierhof, Y.-D., Fuchs, M. and Overath, P (1995). The role of macrophage receptors in adhesion and uptake of Leishmania mexicana amastigotes. J. Cell Sci 108, 3715-3724.[Abstract]

Pimenta, P. F. P., Saraiva, E. M. B. and Sacks, D. L (1991). The finestructure and surface glycoconjugate expression of three life stages of Leishmania major . Exp. Parasitol 72, 191-204.

Prina, E., Antoine, J. C., Weideranders, B. and Kirschke, H (1990). Localization and activity of various lysosomal proteases in Leishmania amazonensis infected macrophages. Infect. Immun 58, 1730-1737.[Abstract/Free Full Text]

Prina, E., Jouanne, C. and de Souza Lao, S (1993). Antigen presentation capacity of murine macrophages infected Leishmania amazonensis amastigotes. J. Immunol 151, 2050-2061.[Abstract]

Prina, E., Lang, T., Glaichenhaus, N. and Antoine, J.-C (1996). Presentation of the protective parasite antigen LACK by Leishmania -infected macrophages. J. Immunol 156, 4318-4327.[Abstract]

Proudfoot, L., O'Donnell, C. A. and Liew, F. Y (1995). Glycoinositolphospholipids of Leishmania major inhibit nitric oxide synthesis and reduce leishmanicidal activity in murine macrophages. Eur. J. Immunol 25, 745-750.[Medline]

Proudfoot, L., Nikolaev, A. V., Feng, G. J., Wei, X. Q., Ferguson, M. A. J., Brimacombe, J. S. and Liew, F. Y (1996). Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lysophosphoglycan in murine macrophages. Proc. Nat. Acad. Sci. USA 93, 10984-10989.[Abstract/Free Full Text]

Puentas, S. M., da Silva, R. P., Sacks, D. L., Hammer, C. H. and Joiner, K. A (1991). Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5-9. J. Immunol 145, 4311-4416.[Abstract]

Ramamoorthy, R., Donelson, J. E., Paetz, K. E., Maybodi, M., Roberts, S. C. and Wilson, M. E (1992). Three distinct RNAs for the surface protease gp63 are differentially expressed during development Leishmania donovani chagasi promastigotes to an infectious form. J. Biol. Chem 267, 1888-1895.[Abstract/Free Full Text]

Reiner, N. E., Ng, W. and McMaster, W. R (1987). Parasite accessory cell interactions in murine leishmaniasis. II. Leishmania donovani suppresses macrophage expression of class I and class II major histocompatibility complex gene products. J.Immunol 138, 1926-1932.[Abstract]

Reiner, N. E., Ng, W., Wilson, C. B., McMaster, W. R. and Burchett, S. K (1990). Modulation of in vitro monocyte cytokine responses to Leishmania donovani . Interferon-presents parasite-induced inhibition of interleukin I production and prime tumor necrosis factor-x and interleukin 1. J. Clin. Invest 85, 1914-1924.

Reiner, S. L., Zheng, S., Wang, Z. E., Stowring, L. and Locksley, R. M (1994). Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection. J. Exp. Med 179, 447-456.[Abstract/Free Full Text]

Rizvi, F. S., Quassi, M. A., Marty, B., Santoro, F. and Capron, A (1988). The major surface protein Leishmania promastigotes in a fibronectin-like molecule. Eur. J.Immunol 18, 473-476.[Medline]

Rodrigues, V., Santana da Silva, J. and Campos-Neto, A (1998). Transforming growth factor beta and immunosupression in experimental visceral leishmaniasis. Infect. Immun 66, 1233-1236.[Abstract/Free Full Text]

Rosat, J. P., McDonald, H. R. and Louis, J. A (1993). A role forT cells during experimental infection of mice with Leishmania major. J. Immunol 150, 550-555.[Abstract]

Russell, D. G. and Wilhelm, H (1986). The involvement of a major surface glycoprotein (gp63) of Leishmania promastigotes in attachment to macrophages. J.Immunol 136, 2613-2620.[Abstract]

Russell, D. G. and Alexander, J (1988). Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes. J.Immunol 140, 1274-1279.[Abstract]

Russell, D. G., Xu, S. and Chakraborty, P (1992). Intracellular trafficking and the parasitophorous vacuole of Leishmania mexicana -infected macrophages. J. Cell Sci 103, 1193-1210.[Abstract/Free Full Text]

Russell, D. G (1994). Biology of the Leishmania surface: with particular reference to the surface proteinase gp63. Protoplasma 181, 191-201.

Sacks, D. L. and Perkins, P. V (1985). Development of infective stage Leishmania promastigotes within phlebotomine sandflies. Am. J. Trop. Med. Hyg 34, 456-459.

Sacks, D. L., Pimenta, P. F., McConville, M. J., Schneider, P. and Turco, S. J (1995). Stage-specific binding of Leishmania donovani to the sand fly vector midgut is regulated by conformational changes in the abundant surface lipophosphoglycan. J.Exp. Med 181, 685-697.[Abstract/Free Full Text]

Saha, B., Das, G., Vohra, H., Ganguly, N. K. and Mishra, G. C (1995). Macrophage-T cell interaction in experimental visceral leishmaniasis: failure to express costimulatory molecules on Leishmania -infected macrophages and its implication in the suppression of cell mediated immunity. Eur. J. Immunol 25, 2492-2498.[Medline]

Sartori, A., Oliveira, M. A. P., Scott, P. and Trinchieri, G (1997). Metacyclogenesis modulates the ability of Leishmania promastigotes to induce IL-12 production in human mononuclear cells. J. Immunol 159, 2849-2857.[Abstract]

Satoskar, A., Bluethmann, H. and Alexander, J (1995). Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection. Infec. Immun 63, 4894-4899.[Abstract]

Satoskar, A., Okano, M. and David, J. R (1997). T cells are not essential for control of cutaneous Leishmania major infection in genetically resistant C57BL/6 mice. J. Infect. Dis 176, 1649-1652.[Medline]

Satoskar, A., Brombacher, F., Dai, W. J., McInnes, I., Liew, F. Y., Alexander, J. and Walker, W (1997). SCID mice reconstituted with IL-4 deficient lymphocytes, but not immunocompetent lymphocytes, are resistant to cutaneous leishmaniasis. J. Immunol 159, 5005-5013.[Abstract]

Satoskar, A. R., Okano, M., Connaughton, S., Raisanen-Sokolwski, A., David, J. R. and Labow, M (1998). Enhanced Th2-like responses in IL-1 type 1 receptor-deficient mice. Eur. J. Immunol 28, 2066-2074.[Medline]

Schaible, U. E., Schlesinger, P. H., Steinberg, T. H., Mangel, W. F., Kobayashi, T. and Russell, D. G (1999). Parasitophorous vacuoles of Leishmania mexicana acquire macromolecules from the host cell cytosol via two independent routes. J. Cell Sci 112, 681-693.[Abstract]

Scharton-Kersten, T., Afonso, L. C. C., Wysocka, M., Trinchieri, G. and Scott, P (1995). IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol 154, 5312-5330.

Scott, P., Eaton, A., Gause, W. C., di Zhou, X. and Hondowicz, B (1996). Early IL-4 production does not predict susceptibility to Leishmania major. Exp. Parasitol 84, 178-187.[Medline]

Seay, M. B., Heard, P. L. and Chaudhari, G (1996). Surface Zn-proteinase as a molecule for defense of Leishmania mexicanaamazonenesis promastigotes against cytolysis inside macrophage phagolysosomes. Infect. Immun 64, 5129-5137.[Abstract]

Soares, M. B. P., Titus, R. G., Schoemaker, C. B., David, J. R. and Bozza, M (1998). The vasoactive peptide maxadilan from sandfly saliva inhibits TNF-and induces IL-6 by mouse macrophages through interaction with the PACAP receptor. J. Immunol 160, 1811-1816.[Abstract/Free Full Text]

Soong, L., Xu, J.-C., Grewal, I. S., Kima, P., Sun, J., Longley, B. J., Ruddle, N. H., McMahon-Pratt, D. and Flavell, R. A (1996). Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4, 263-273.[Medline]

Sorensen, A. L., Hey, A. S. and Kharazmi, A (1994). Leishmania major surface protease gp63 interferes with the function of human monocytes and neutrophils in vitro. APMIS 102, 265-271.[Medline]

Stamm, L., Raisanen-Sokolwski, A., Okano, M., Russell, M. E., David, J. R. and Satoskar, A. R (1998). Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous leishmaniasis. J. Immunol 161, 6180-6188.[Abstract/Free Full Text]

Stenger, S., Thuring, H., Rollinghoff, M. and Bogdan, C (1994). Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med 180, 783-793.[Abstract/Free Full Text]

Sturgill-Koszycki, S., Schlessinger, P. H., Chakraborty, P., Haddix, P. L., Collins, H. L., Fok, A. K., Allen, R. D., Gluck, S. L., Heuser, J. and Russell, D. G (1994). Lack of acidification in Mycobacterium phagosomesproduced by exclusion of the vesicular proton-ATPase. Science 263, 678-681.[Abstract/Free Full Text]

Sypek, J. P., Chung, C. L., Mayor, S. E. H., Subramanyam, J. M., Goldman, S. J., Sieburth, D. S., Wolf, S. F. and Schaub, R. G (1993). Resolution of cutaneous leishmaniasis: interleukin-12 initiates a protective T helper type 1 immune response. J.Exp. Med 177, 1797-1802.[Abstract/Free Full Text]

Talamas-Rohana, P., Wright, S. D., Lennartz, M. and Russell, D. G (1990). Lipophophoglycan (LPG) of Leishmania mexicana promastigotes binds to the CR3, p150/95 and LFA-1 family of leukocyte integrins. J. Immunol 144, 4817-4824.[Abstract]

Taylor, A. P. and Murray, H. W (1997). Intracellular antimicrobial activity in the absence of interferon-gamma: effect of interleukin-12 in experimental visceral leishmaniasis in interferon-gamma gene-disrupted mice. J. Exp. Med 185, 1231-1239.[Abstract/Free Full Text]

Theodos, C. M., Shankar, A., Glasebrook, A. L., Roeder, W. D. and Titus, R. G (1994). The effect of treating with anti-interleukin-1 receptor antibody on the course of experimental murine cutaneous leishmaniasis. Parasite Immunol 16, 571-577.[Medline]

Turco, S. J. and Descoteaux, A (1992). The lipophosphoglycan of Leishmania parasites. Annu. Rev. Microbiol 46, 65-94.[Medline]

Vouldoukis, I., Riveros-Moreno, V., Dugas, B., Ouaaz, F., Becherel, P., Debre, P., Salvador, M. and Mossalayi, M. D (1995). The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the FcandRII/Cd23 surface antigen. Proc. Nat. Acad. Sci. USA 92, 7804-7808.[Abstract/Free Full Text]

Vouldoukis, I., Becherel, P. A., Riveros-Moreno, V., Arock, M., da Silva, O., Debre, P., Mazier, D. and Mossalayi, M. D (1997). Interleukin-10 and interleukin-4 inhibits intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation. Eur. J. Immunol 27, 860-865.[Medline]

Weinheber, N., Wolfram, M., Harbecke, D. and Aebischer, T (1998). Phagocytosis of Leishmania mexicana amastigotes by macrophages leads to a sustained suppression of IL-12. Eur. J. Immunol 28, 2467-2477.[Medline]

Wilson, M. E. and Pearson, R. D (1986). Evidence that Leishmania donovani utilises a mannose receptor on human mononuclear phagocytes to establish intracellular parasitism. J. Immunol 136, 4681-4687.[Abstract]

Wolfranm, M., Fuchs, M., Wiese, M., Stierhof, Y.-D. and Overath, P (1996). Antigen presentation by Leishmania mexicana infected macrophages: activation of helper T cells by a model parasite antigen secreted into the parasitophorous vacuole or expressed on the amastigote surface. Eur. J. Immunol 26, 3153-3162.[Medline]

Wyler, D. J., Sypec, J. P. and McDonald, J. A (1985). In vitro parasite monocyte interactions in human leishmaniasis: possible role of fibronectin in parasite atttachment. Infect. Immun 49, 305-311.[Abstract/Free Full Text]

Yoshimoto, T., Ohkusu, K., Okamura, H. and Nakanishi, K (1998). Induction of host resistance to Leishmania major by IL-12 and IL-18:in vivo IL-12 treatment upregulates IL-18 receptor expression of T cells. FASEB J 12, 1068-.

This article has been cited by other articles:

D. A. Vargas-Inchaustegui, L. Xin, and L. Soong
Leishmania braziliensis Infection Induces Dendritic Cell Activation, ISG15 Transcription, and the Generation of Protective Immune Responses
J. Immunol., June 1, 2008; 180(11): 7537 - 7545.
[Abstract] [Full Text] [PDF]

R. Silvestre, A. Cordeiro-Da-Silva, N. Santarem, B. Vergnes, D. Sereno, and A. Ouaissi
SIR2-Deficient Leishmania infantum Induces a Defined IFN-{gamma}/IL-10 Pattern That Correlates with Protection
J. Immunol., September 1, 2007; 179(5): 3161 - 3170.
[Abstract] [Full Text] [PDF]

R. Dey, N. Majumder, S. Bhattacharjee, S. B. Majumdar, R. Banerjee, S. Ganguly, P. Das, and S. Majumdar
Leishmania donovani-Induced Ceramide as the Key Mediator of Akt Dephosphorylation in Murine Macrophages: Role of Protein Kinase C{zeta} and Phosphatase
Infect. Immun., May 1, 2007; 75(5): 2136 - 2142.
[Abstract] [Full Text] [PDF]

L. E. Rosas, H. M. Snider, J. Barbi, A. A. Satoskar, G. Lugo-Villarino, T. Keiser, T. Papenfuss, J. E. Durbin, D. Radzioch, L. H. Glimcher, et al.
Cutting Edge: STAT1 and T-bet Play Distinct Roles in Determining Outcome of Visceral Leishmaniasis Caused by Leishmania donovani
J. Immunol., July 1, 2006; 177(1): 22 - 25.
[Abstract] [Full Text] [PDF]

S. Besteiro, R. A. M. Williams, L. S. Morrison, G. H. Coombs, and J. C. Mottram
Endosome Sorting and Autophagy Are Essential for Differentiation and Virulence of Leishmania major
J. Biol. Chem., April 21, 2006; 281(16): 11384 - 11396.
[Abstract] [Full Text] [PDF]

C. Holscher, B. Arendse, A. Schwegmann, E. Myburgh, and F. Brombacher
Impairment of Alternative Macrophage Activation Delays Cutaneous Leishmaniasis in Nonhealing BALB/c Mice
J. Immunol., January 15, 2006; 176(2): 1115 - 1121.
[Abstract] [Full Text] [PDF]

L. E. Rosas, A. A. Satoskar, K. M. Roth, T. L. Keiser, J. Barbi, C. Hunter, F. J. de Sauvage, and A. R. Satoskar
Interleukin-27R (WSX-1/T-Cell Cytokine Receptor) Gene-Deficient Mice Display Enhanced Resistance to Leishmania donovani Infection but Develop Severe Liver Immunopathology
Am. J. Pathol., January 1, 2006; 168(1): 158 - 169.
[Abstract] [Full Text] [PDF]

L. E. Rosas, T. Keiser, J. Barbi, A. A. Satoskar, A. Septer, J. Kaczmarek, C. M. Lezama-Davila, and A. R. Satoskar
Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice
Int. Immunol., October 1, 2005; 17(10): 1347 - 1357.
[Abstract] [Full Text] [PDF]

P. Cameron, A. McGachy, M. Anderson, A. Paul, G. H. Coombs, J. C. Mottram, J. Alexander, and R. Plevin
Inhibition of Lipopolysaccharide-Induced Macrophage IL-12 Production by Leishmania mexicana Amastigotes: The Role of Cysteine Peptidases and the NF-{kappa}B Signaling Pathway
J. Immunol., September 1, 2004; 173(5): 3297 - 3304.
[Abstract] [Full Text] [PDF]

T. Baldwin, S. Henri, J. Curtis, M. O'Keeffe, D. Vremec, K. Shortman, and E. Handman
Dendritic Cell Populations in Leishmania major-Infected Skin and Draining Lymph Nodes
Infect. Immun., April 1, 2004; 72(4): 1991 - 2001.
[Abstract] [Full Text] [PDF]

M. Saeftel, M. Arndt, S. Specht, L. Volkmann, and A. Hoerauf
Synergism of Gamma Interferon and Interleukin-5 in the Control of Murine Filariasis
Infect. Immun., December 1, 2003; 71(12): 6978 - 6985.
[Abstract] [Full Text] [PDF]

U. M. Padigel, J. Alexander, and J. P. Farrell
The Role of Interleukin-10 in Susceptibility of BALB/c Mice to Infection with Leishmania mexicana and Leishmania amazonensis
J. Immunol., October 1, 2003; 171(7): 3705 - 3710.
[Abstract] [Full Text] [PDF]

G. F. Spath, L. A. Garraway, S. J. Turco, and S. M. Beverley
The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts
PNAS, August 5, 2003; 100(16): 9536 - 9541.
[Abstract] [Full Text] [PDF]

M. d. S. S. Rosa, R. R. Mendonca-Filho, H. R. Bizzo, I. d. A. Rodrigues, R. M. A. Soares, T. Souto-Padron, C. S. Alviano, and A. H. C. S. Lopes
Antileishmanial Activity of a Linalool-Rich Essential Oil from Croton cajucara
Antimicrob. Agents Chemother., June 1, 2003; 47(6): 1895 - 1901.
[Abstract] [Full Text] [PDF]

L. Corcoran, D. Vremec, M. Febbraio, T. Baldwin, and E. Handman
Differential regulation of CD36 expression in antigen-presenting cells: Oct-2 dependence in B lymphocytes but not dendritic cells or macrophages
Int. Immunol., October 1, 2002; 14(10): 1099 - 1104.
[Abstract] [Full Text] [PDF]

J. Morehead, I. Coppens, and N. W. Andrews
Opsonization Modulates Rac-1 Activation during Cell Entry by Leishmania amazonensis
Infect. Immun., August 1, 2002; 70(8): 4571 - 4580.
[Abstract] [Full Text] [PDF]

S. Henri, J. Curtis, H. Hochrein, D. Vremec, K. Shortman, and E. Handman
Hierarchy of Susceptibility of Dendritic Cell Subsets to Infection by Leishmania major: Inverse Relationship to Interleukin-12 Production
Infect. Immun., July 1, 2002; 70(7): 3874 - 3880.
[Abstract] [Full Text] [PDF]

C. W. Roberts, W. Walker, and J. Alexander
Sex-Associated Hormones and Immunity to Protozoan Parasites
Clin. Microbiol. Rev., July 1, 2001; 14(3): 476 - 488.
[Abstract] [Full Text] [PDF]

A. R. Satoskar, M. Bozza, M. Rodriguez Sosa, G. Lin, and J. R. David
Migration-Inhibitory Factor Gene-Deficient Mice Are Susceptible to Cutaneous Leishmania major Infection
Infect. Immun., February 1, 2001; 69(2): 906 - 911.
[Abstract] [Full Text] [PDF]

G. M. Monteforte, K. Takeda, M. Rodriguez-Sosa, S. Akira, J. R. David, and A. R. Satoskar
Genetically Resistant Mice Lacking IL-18 Gene Develop Th1 Response and Control Cutaneous Leishmania major Infection
J. Immunol., June 1, 2000; 164(11): 5890 - 5893.
[Abstract] [Full Text] [PDF]

This Article

Summary

Full Text (PDF)

Alert me when this article is cited

Alert me if a correction is posted

Services

Email this article to a friend

Similar articles in this journal

Similar articles in PubMed

Alert me to new issues of the journal

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via Google Scholar

Google Scholar

Articles by Alexander, J.

Articles by Russell, D. G.

Search for Related Content

PubMed

PubMed Citation

Articles by Alexander, J.

Articles by Russell, D. G.

				R. Silvestre, A. Cordeiro-Da-Silva, N. Santarem, B. Vergnes, D. Sereno, and A. Ouaissi SIR2-Deficient Leishmania infantum Induces a Defined IFN-{gamma}/IL-10 Pattern That Correlates with Protection J. Immunol., September 1, 2007; 179(5): 3161 - 3170. [Abstract] [Full Text] [PDF]

				R. Dey, N. Majumder, S. Bhattacharjee, S. B. Majumdar, R. Banerjee, S. Ganguly, P. Das, and S. Majumdar Leishmania donovani-Induced Ceramide as the Key Mediator of Akt Dephosphorylation in Murine Macrophages: Role of Protein Kinase C{zeta} and Phosphatase Infect. Immun., May 1, 2007; 75(5): 2136 - 2142. [Abstract] [Full Text] [PDF]

				L. E. Rosas, H. M. Snider, J. Barbi, A. A. Satoskar, G. Lugo-Villarino, T. Keiser, T. Papenfuss, J. E. Durbin, D. Radzioch, L. H. Glimcher, et al. Cutting Edge: STAT1 and T-bet Play Distinct Roles in Determining Outcome of Visceral Leishmaniasis Caused by Leishmania donovani J. Immunol., July 1, 2006; 177(1): 22 - 25. [Abstract] [Full Text] [PDF]

				S. Besteiro, R. A. M. Williams, L. S. Morrison, G. H. Coombs, and J. C. Mottram Endosome Sorting and Autophagy Are Essential for Differentiation and Virulence of Leishmania major J. Biol. Chem., April 21, 2006; 281(16): 11384 - 11396. [Abstract] [Full Text] [PDF]

				C. Holscher, B. Arendse, A. Schwegmann, E. Myburgh, and F. Brombacher Impairment of Alternative Macrophage Activation Delays Cutaneous Leishmaniasis in Nonhealing BALB/c Mice J. Immunol., January 15, 2006; 176(2): 1115 - 1121. [Abstract] [Full Text] [PDF]

				L. E. Rosas, A. A. Satoskar, K. M. Roth, T. L. Keiser, J. Barbi, C. Hunter, F. J. de Sauvage, and A. R. Satoskar Interleukin-27R (WSX-1/T-Cell Cytokine Receptor) Gene-Deficient Mice Display Enhanced Resistance to Leishmania donovani Infection but Develop Severe Liver Immunopathology Am. J. Pathol., January 1, 2006; 168(1): 158 - 169. [Abstract] [Full Text] [PDF]

				L. E. Rosas, T. Keiser, J. Barbi, A. A. Satoskar, A. Septer, J. Kaczmarek, C. M. Lezama-Davila, and A. R. Satoskar Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice Int. Immunol., October 1, 2005; 17(10): 1347 - 1357. [Abstract] [Full Text] [PDF]

				P. Cameron, A. McGachy, M. Anderson, A. Paul, G. H. Coombs, J. C. Mottram, J. Alexander, and R. Plevin Inhibition of Lipopolysaccharide-Induced Macrophage IL-12 Production by Leishmania mexicana Amastigotes: The Role of Cysteine Peptidases and the NF-{kappa}B Signaling Pathway J. Immunol., September 1, 2004; 173(5): 3297 - 3304. [Abstract] [Full Text] [PDF]

				T. Baldwin, S. Henri, J. Curtis, M. O'Keeffe, D. Vremec, K. Shortman, and E. Handman Dendritic Cell Populations in Leishmania major-Infected Skin and Draining Lymph Nodes Infect. Immun., April 1, 2004; 72(4): 1991 - 2001. [Abstract] [Full Text] [PDF]

				M. Saeftel, M. Arndt, S. Specht, L. Volkmann, and A. Hoerauf Synergism of Gamma Interferon and Interleukin-5 in the Control of Murine Filariasis Infect. Immun., December 1, 2003; 71(12): 6978 - 6985. [Abstract] [Full Text] [PDF]

				U. M. Padigel, J. Alexander, and J. P. Farrell The Role of Interleukin-10 in Susceptibility of BALB/c Mice to Infection with Leishmania mexicana and Leishmania amazonensis J. Immunol., October 1, 2003; 171(7): 3705 - 3710. [Abstract] [Full Text] [PDF]

				G. F. Spath, L. A. Garraway, S. J. Turco, and S. M. Beverley The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts PNAS, August 5, 2003; 100(16): 9536 - 9541. [Abstract] [Full Text] [PDF]

				M. d. S. S. Rosa, R. R. Mendonca-Filho, H. R. Bizzo, I. d. A. Rodrigues, R. M. A. Soares, T. Souto-Padron, C. S. Alviano, and A. H. C. S. Lopes Antileishmanial Activity of a Linalool-Rich Essential Oil from Croton cajucara Antimicrob. Agents Chemother., June 1, 2003; 47(6): 1895 - 1901. [Abstract] [Full Text] [PDF]

				L. Corcoran, D. Vremec, M. Febbraio, T. Baldwin, and E. Handman Differential regulation of CD36 expression in antigen-presenting cells: Oct-2 dependence in B lymphocytes but not dendritic cells or macrophages Int. Immunol., October 1, 2002; 14(10): 1099 - 1104. [Abstract] [Full Text] [PDF]

				J. Morehead, I. Coppens, and N. W. Andrews Opsonization Modulates Rac-1 Activation during Cell Entry by Leishmania amazonensis Infect. Immun., August 1, 2002; 70(8): 4571 - 4580. [Abstract] [Full Text] [PDF]

				S. Henri, J. Curtis, H. Hochrein, D. Vremec, K. Shortman, and E. Handman Hierarchy of Susceptibility of Dendritic Cell Subsets to Infection by Leishmania major: Inverse Relationship to Interleukin-12 Production Infect. Immun., July 1, 2002; 70(7): 3874 - 3880. [Abstract] [Full Text] [PDF]

				C. W. Roberts, W. Walker, and J. Alexander Sex-Associated Hormones and Immunity to Protozoan Parasites Clin. Microbiol. Rev., July 1, 2001; 14(3): 476 - 488. [Abstract] [Full Text] [PDF]

				A. R. Satoskar, M. Bozza, M. Rodriguez Sosa, G. Lin, and J. R. David Migration-Inhibitory Factor Gene-Deficient Mice Are Susceptible to Cutaneous Leishmania major Infection Infect. Immun., February 1, 2001; 69(2): 906 - 911. [Abstract] [Full Text] [PDF]

				G. M. Monteforte, K. Takeda, M. Rodriguez-Sosa, S. Akira, J. R. David, and A. R. Satoskar Genetically Resistant Mice Lacking IL-18 Gene Develop Th1 Response and Control Cutaneous Leishmania major Infection J. Immunol., June 1, 2000; 164(11): 5890 - 5893. [Abstract] [Full Text] [PDF]